Abstract
BACKGROUND: Malignant tumors present challenges such as high heterogeneity and the limitations of traditional therapies, driving innovations in nanomedicine, particularly in the development of micro/nanomotors. These autonomous devices offer superior tumor penetration capabilities but and lack systematic bibliometric insights. METHOD: Data from WoSCC (2006-2025) were analyzed using bibliometric tools (CiteSpace, VOSviewer, and "bibliometrics") to map research landscapes. RESULTS: A total of 10,609 articles from 38 countries were identified, with annual output growing at a compound annual growth rate (CAGR) of 22% and peaking at 126 articles in 2024. China led globally with 380 publications (62.4%). The Chinese Academy of Sciences (123 articles) emerged as the leading institution in this domain, while ACS NANO (36 articles) was identified as the most prolific and co-cited journal. Wang J contributed the highest number of articles, and publications by Wang J also exhibited the highest co-citation frequency. The keyword "penetration" exhibited the strongest citation burst (2021-2025), reflecting breakthroughs in overcoming tumor physical barriers. CONCLUSION: This study highlights China's dominance, rapid technological evolution toward intelligent actuation and immunotherapy integration, and "penetration" as a pivotal frontier. Findings provide strategic guidance for future research and clinical translation.